Nabothian Cyst Protects or Facilitates Against Cervical Cancer
Naboth Kisti ve HPV pozitifliği arasındaki ilişkinin araştırılması
1 other identifier
observational
1,005
1 country
1
Brief Summary
Aim of the study to asses the realition between HPV infection, Nabothian Cyst and Cervical Intraepithelial lesions or Cervical Cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2020
CompletedStudy Start
First participant enrolled
July 23, 2020
CompletedFirst Posted
Study publicly available on registry
July 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedJuly 28, 2020
July 1, 2020
7 months
July 16, 2020
July 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Nabothian cyst affects the HPV infection in cervix
in the research, results will be compared for to figure out the relation; nabothian cyst how affects HPV infection , how causes cervical dysplasia in cervix.
through study completion, an average of 1 year
Secondary Outcomes (1)
Does the other factors(like cigarette, birth number, vaginitis) affect HPV infection and Cervical Cancer
through study completion, an average of 1 year
Study Arms (3)
the woman who has just HPV infection
the woman who is between 30-65 years old, who is participate this research, and has just HPV infection in cervix.
the woman who has just nabothian cyst
the woman who is between 30-65 years old, who is participate this research, and has just nabothian cyst in cervix.
the woman who has both nabothian cyst and HPV infection
the woman who is between 30-65 years old, who is participate this research, and has both nabothian cyst in cervix.
Interventions
In the end of the Research, we will compare cervical cancer rates between groups
Eligibility Criteria
the woman; who is between 25-65 years of age, who goes to Haseki Education and Research Hospital Gynecology and Oncology Outpatient Clinic, who has nabothian cyst and/ or HPV infection
You may qualify if:
- To have Naboth cyst and/or HPV positivity Must be willing and able to provide informed consent Comply with the study protocol Between 25-65 age range
You may not qualify if:
- To Refuse participate in our research The age under 25 and over 65 Ovarian, endometrial and vulvar malignancies Without both Naboth's cyst and HPV positivity To have LEEP/Cervical Conization before History of Cervical Dysplasia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cihan Comba
Istanbul, Sultangazi, 34265, Turkey (Türkiye)
Related Publications (4)
Malagon T, Volesky KD, Bouten S, Laprise C, El-Zein M, Franco EL. Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis. Int J Cancer. 2020 Nov 15;147(10):2695-2707. doi: 10.1002/ijc.33035. Epub 2020 May 26.
PMID: 32363604BACKGROUNDIsoda T, BaBa S, Maruoka Y, Kitamura Y, Nishie A, Sasaki M, Honda H. Nabothian cyst a predominant cause of false-positive iodine uptake in uterus: comparison of SPECT/CT and pelvic MRI. Clin Nucl Med. 2014 Aug;39(8):680-4. doi: 10.1097/RLU.0000000000000504.
PMID: 24978344BACKGROUNDBarrigon A, Ziadi S, Jacot-Guillarmod M, Da Silva S, Dumont M, Raineri I, Bongiovanni M. Nabothian cyst content: A potential pitfall for the diagnosis of invasive cancer on Pap test cytology. Diagn Cytopathol. 2019 Feb;47(2):127-129. doi: 10.1002/dc.24098. Epub 2018 Oct 24.
PMID: 30353714RESULTD'Alessandro P, Giudicepietro A, Della Corte L, Arduino B, Saccone G, Iacobelli A, Insabato L, Zullo F. A case of gastric-type mucinous endocervical adenocarcinoma in presence of nabothian cysts. Eur J Obstet Gynecol Reprod Biol. 2019 May;236:254-255. doi: 10.1016/j.ejogrb.2019.02.024. Epub 2019 Mar 2. No abstract available.
PMID: 30878235RESULT
Biospecimen
Cervical swap samples will be used as Biospecimen to get know whether there is HPV infection in cervix, and which tipe of HPV infection occurs in patients' cervix
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Cihan Comba, MD
Sultangazi Haseki Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- gynecological oncology specialist
Study Record Dates
First Submitted
July 16, 2020
First Posted
July 28, 2020
Study Start
July 23, 2020
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
July 28, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share